Navigation Links
Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
Date:7/2/2009

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

The new prediction method comprises the length of time it takes for PSA (prostate-specific antigen) to double, Gleason score (a numeric indicator of prostate cancer aggressiveness as seen under the microscope), and the interval between surgical removal of the prostate and the first detectable PSA level. According to Johns Hopkins investigators, combining these three measurements more accurately estimates risk that the cancer has spread than do other methods and should help determine which patients may benefit from additional therapy when PSA levels rise after surgery to remove the prostate.

Findings from the study presented at the June 2009 annual meeting of the American Society of Clinical Oncology (ASCO) may also help resolve the debate on when and in what form secondary treatments should occur.

"There is much debate on whether to prescribe immediate treatment for a man whose PSA begins to rise after he has had prostate cancer surgery, or to delay it," says Emmanuel Antonarakis, M.D., Johns Hopkins Kimmel Cancer Center investigator. "Studies suggest that most men live the same length of time overall whether they receive therapy at the first sign of a rising PSA or wait until the cancer has spread to other sites."

After reviewing the records of 774 men whose PSA rose after surgery to remove the prostate, the researchers found that Gleason score and two measurements for PSA were the strongest risk factors for prostate cancer metastasis. Men with Gleason scores in the highest range, between eight and 10, were twice as likely to develop metastatic cancer. In men whose PSA became detectable within three years after surgery, cancer was more than three times more likely to spread to other organs. Finally, m
'/>"/>

Contact: Amy Mone
amone1@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Predicting fatal fungal infections
2. Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs
3. Predicting higher risk for prostate cancer diagnosis
4. U study shows MRI-based method holds promise for predicting treatment outcomes in patients with AF
5. Systolic and diastolic blood pressures together more useful for predicting cardiovascular risk
6. Progress Made in Predicting Breast Cancer Risk
7. Researchers discover strategy for predicting the immunity of vaccines
8. Genetic Testing No Real Help in Predicting Type 2 Diabetes
9. Predicting the future for patients with severe traumatic brain injury
10. Novel imaging approach may assist in predicting success of treatment for atrial fibrillation
11. Prototype test for predicting clinical outcome for melanoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Dr. Omar Ibrahimi, Dermatologist and ... CT has been selected as part of a controlled ... (and the only physician in Connecticut) to offer the ... the removal of submental fat (double chin). The procedure ... no surgery and minimal risks. Dr. Ibrahimi is an ...
(Date:5/27/2015)... Clearwater, Florida (PRWEB) May 27, 2015 ... accurate, impartial customer satisfaction surveys in the multiple ... user poll to determine the highest ranked Electronic ... As part of a special research focus on ... and announced those software vendors with the highest ...
(Date:5/27/2015)... Rock, AR (PRWEB) May 27, 2015 ... Medix today announce a partnership to provide CMSA's ... Medix community. This collaboration seeks to strengthen the ... measurement through CMSA’s CKP program. The mutually beneficial ... on identifying individual skills of talent in the ...
(Date:5/27/2015)... 27, 2015 Difass USA, a modern ... U.S. with its first three flagship products, Dormiva™, Relaxiva™ ... nationwide through http://www.difassusa.com . , A restful ... productivity, but some people struggle with getting the full ... a sleep aid designed to help you fall asleep ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
Breaking Medicine News(10 mins):Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2
... the University of Minnesota have found that cerebral malaria is related ... research is published in the current issue of the journal ... Malaria is a leading cause of death ... than 750,000 children a year, is one of the deadliest forms ...
... Mich., July 29 Stryker Corporation,(NYSE: SYK ) ... conference:, August 6, 2008 - 11:15 a.m. ... Conference New York, New York, A simultaneous ... website at http://www.stryker.com via the For Investors ...
... show that regular,monitoring of medications by physicians is ... health. Thanks to recent advances in the SMART,Registry, ... about their,patients that they never received before., ... how regularly,their chronically ill patients fill their prescriptions., ...
... developed a novel approach to treating advanced prostate cancer ... , Professor Wayne Tilley and Dr Lisa Butler of ... discovered that by using existing prostate cancer drugs in ... expect to generate better results for patients than current ...
... up in motor neurons , , TUESDAY, July 29 (HealthDay ... amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... University and Harvard Medical School. , ALS is a ... neurons in the brain and spinal cord that control ...
... the Clinical Gold Standard Drug Through 2016, According ... to a New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical and,healthcare ... has a lower discontinuation rate than that of Abbott,s,Niaspan ER ...
Cached Medicine News:Health News:U of M researchers find cerebral malaria may be a major cause of brain injury in African children 2Health News:Stryker To Present at Investor Conference 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 3Health News:New treatment for advanced prostate cancer 2Health News:Scientists ID 'Jekyll-Hyde' Protein in Lou Gehrig's Disease 2Health News:A High-Density Lipoprotein Raising Drug That Has a Lower Discontinuation Rate Than That of Extended Release Niaspan Would Earn a 20 Percent Patient Share in the Dyslipidemia Drug Market 2
(Date:5/27/2015)... May 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ... Pacific Fluoroscopy Market - Growth, Trends And Forecasts (2014 ... The Asia Pacific market ... CAGR from 2014 to 2020 Fluoroscopy is ... moving images of the interior of the body. The ...
(Date:5/27/2015)... a senior marketing associate with the animal health division of Eli Lilly ... healthcare setting in Bangkok, Thailand , will be among ... with respect and dignity is the guiding star for me and my ... a LillyPad blog . Donatelli and Lilly colleagues from ... Colombia , France , Ukraine ...
(Date:5/27/2015)... , May 25, 2015 Research ... of the "2015 Strategies in the Global ... This comprehensive seven-country report contains 650 ... current suppliers and potential market entrants identify and ... testing market during the next five years. ...
Breaking Medicine Technology:Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3Global Coagulation Testing Market Strategies 2015 2Global Coagulation Testing Market Strategies 2015 3
... Sept. 20 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... of,cethromycin, the Company,s lead compound, at the 47th ... September,17 - 20. A total of seven poster ... Eurofins Medinet and Micromyx, discussed in vitro,activity of ...
... -- When compared to insulin glargine, exenatide offered ... beta-cell function when used with metformin --, ... AMLN ) and Eli Lilly and Company ... treatment of exenatide injection,with insulin glargine on beta-cell ...
Cached Medicine Technology:Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: